• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[微量中和试验在流感感染诊断中的应用]

[Microneutralization assay in the diagnosis of influenza infection].

作者信息

Havlicková Martina, Jirincová Helena, Maresová Vilma, Dzupová Olga, Limberková Radomíra

机构信息

Státní zdravotní ústav, Centrum epidemiologie a mikrobiologie, Praha.

出版信息

Epidemiol Mikrobiol Imunol. 2012 May;61(1-2):9-14.

PMID:22880259
Abstract

Serology plays an important role in the diagnosis of influenza, particularly in the detection of post-vaccination and post-infection antibodies. When considering the range of diagnostic options, the serological method should be selected depending on the circumstances - whether single or paired serum samples are tested, whether adequate patient medical history data are available, whether epidemiological links are suspected, and, in particular, to what purpose the result will be used (differential diagnosis, post-infection follow-up, post-vaccination monitoring, etc.). The virus neutralization assay is one of the most sensitive and most objective serological tests, but it is highly dependent on the reaction balance and quality of the virus used. Determining the protective titer is crucial for the routine practice. Based on our experiments, we concluded that the virus neutralizing antibody titers are up to eight times as high in comparison with the hemaglutination inhibition test (HIT) or complement fixation reaction (CFR), but the correlation varies and is significantly influenced by interindividual variation in anti-neuraminidase antibodies and those against some internal proteins of influenza virus. We assume that the protective titer in the virus neutralization assay will be not less than 1:80. The predictive value of the titers below 1:40 is questionable.

摘要

血清学在流感诊断中起着重要作用,尤其是在检测疫苗接种后和感染后的抗体方面。在考虑一系列诊断选项时,应根据具体情况选择血清学方法,例如是否检测单份或双份血清样本、是否有足够的患者病史数据、是否怀疑存在流行病学关联,特别是检测结果将用于何种目的(鉴别诊断、感染后随访、疫苗接种后监测等)。病毒中和试验是最敏感、最客观的血清学检测方法之一,但它高度依赖于反应平衡和所用病毒的质量。确定保护性滴度对常规实践至关重要。基于我们的实验,我们得出结论,与血凝抑制试验(HIT)或补体结合反应(CFR)相比,病毒中和抗体滴度高达八倍,但相关性有所不同,并且受到抗神经氨酸酶抗体以及针对流感病毒某些内部蛋白的抗体个体差异的显著影响。我们假设病毒中和试验中的保护性滴度将不低于1:80。低于1:40的滴度的预测价值值得怀疑。

相似文献

1
[Microneutralization assay in the diagnosis of influenza infection].[微量中和试验在流感感染诊断中的应用]
Epidemiol Mikrobiol Imunol. 2012 May;61(1-2):9-14.
2
Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus.比较血凝抑制试验、基于 ELISA 的微量中和试验和比色微量中和试验检测针对甲型 H1N1 2009 流感病毒疫苗的抗体反应。
J Virol Methods. 2011 Feb;171(2):369-73. doi: 10.1016/j.jviromet.2010.11.024. Epub 2010 Dec 10.
3
Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.中和抗体而非血凝抗体可准确评估接种疫苗的兔子对 H5N1 禽流感病毒的保护性免疫反应。
Vaccine. 2011 Jul 26;29(33):5421-3. doi: 10.1016/j.vaccine.2011.05.067. Epub 2011 Jun 7.
4
Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.季节性 H1N1 2007 流感病毒感染与对 2009 年大流行的甲型流感(H1N1)病毒的预先存在抗体滴度升高有关。
Clin Microbiol Infect. 2011 May;17(5):732-7. doi: 10.1111/j.1469-0691.2010.03352.x. Epub 2010 Oct 29.
5
Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin-streptavidin conjugated antibodies.使用特异性生物素-链霉亲和素偶联抗体检测接种疫苗雪貂和猕猴体内的甲型和乙型流感中和抗体。
J Virol Methods. 2010 Feb;163(2):459-64. doi: 10.1016/j.jviromet.2009.11.014. Epub 2009 Nov 11.
6
Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.利用表达 GFP 的流感病毒检测流感病毒 A/H5N1 中和抗体。
Vaccine. 2011 Apr 18;29(18):3424-30. doi: 10.1016/j.vaccine.2011.02.082. Epub 2011 Mar 9.
7
Population exposure to a novel influenza A virus over three waves of infection.人群在三次感染波中接触新型甲型流感病毒。
J Clin Virol. 2011 Dec;52(4):300-3. doi: 10.1016/j.jcv.2011.08.019. Epub 2011 Sep 15.
8
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.对2009年甲型H1N1流感大流行病毒的交叉反应性抗体应答。
N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.
9
A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.一项旨在确定单价 A/H1N1 流感大流行疫苗在健康成年和老年受试者中最佳抗原和 MF59(®)佐剂剂量的随机临床试验。
Vaccine. 2012 May 14;30(23):3470-7. doi: 10.1016/j.vaccine.2012.03.017. Epub 2012 Mar 22.
10
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.2009 年甲型 H1N1 流感大流行在法国大都市人群中的血清学研究。
Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.